Literature DB >> 9795090

Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway.

G Camenisch1, G Folkers, H van de Waterbeemd.   

Abstract

The objective of this study was to rationalize the shape of membrane permeability-lipophilicity curves, when considering, in addition to the usual transcellular route, a parallel diffusion pathway through aqueous pores as present in biological membranes. The theoretical influence of different pH in donor and acceptor compartment and the molecular weight on the permeability curves was studied. We combined and extended two previously proposed absorption models, namely one describing diffusion through a simple membrane (two stagnant aqueous and two organic layers in series, no pores) as the sum of the two distribution steps at both membrane interfaces, and a second theoretical model considering the sum of different diffusional resistances through stagnant layers and membrane, respectively. Under certain conditions the equivalence of the two-step distribution model and the diffusional resistance model can be demonstrated. Incorporation of an aqueous diffusion pathway leads to an extended two-step distribution model. This theoretical membrane permeation model will permit a more physicochemical-based interpretation of permeation data and shows that combined log D values and molecular weight are important determinants for membrane transport processes through, e.g. Caco-2 monolayers and the mucosal GI membranes. We have demonstrated that the well-known sigmoidal permeability-lipophilicity relationship should be considered as a molecular weight-dependent set of sigmoidal relationships.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795090

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

Review 1.  Lipophilicity and its relationship with passive drug permeation.

Authors:  Xiangli Liu; Bernard Testa; Alfred Fahr
Journal:  Pharm Res       Date:  2010-10-30       Impact factor: 4.200

2.  Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.

Authors:  Lenka Gyürösiová; Leena Laitinen; Johanna Raiman; Jozef Cizmárik; Eva Sedlárová; Jouni Hirvonen
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 3.  Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts.

Authors:  Gian P Camenisch
Journal:  Pharm Res       Date:  2016-07-20       Impact factor: 4.200

4.  Europium coordination complexes as potential anticancer drugs: their partitioning and permeation into lipid bilayers as revealed by pyrene fluorescence quenching.

Authors:  Valeriya Trusova; Andrey Yudintsev; Ludmila Limanskaya; Galyna Gorbenko; Todor Deligeorgiev
Journal:  J Fluoresc       Date:  2012-10-06       Impact factor: 2.217

5.  Computational approaches for modeling human intestinal absorption and permeability.

Authors:  Govindan Subramanian; Douglas B Kitchen
Journal:  J Mol Model       Date:  2006-04-01       Impact factor: 1.810

6.  An in silico transwell device for the study of drug transport and drug-drug interactions.

Authors:  Lana X Garmire; David G Garmire; C Anthony Hunt
Journal:  Pharm Res       Date:  2007-08-17       Impact factor: 4.580

7.  Modeling the release kinetics of poorly water-soluble drug molecules from liposomal nanocarriers.

Authors:  Stephan Loew; Alfred Fahr; Sylvio May
Journal:  J Drug Deliv       Date:  2011-06-07

8.  Intestinal Transport Characteristics and Metabolism of C-Glucosyl Dihydrochalcone, Aspalathin.

Authors:  Sandra Bowles; Elizabeth Joubert; Dalene de Beer; Johan Louw; Christel Brunschwig; Mathew Njoroge; Nina Lawrence; Lubbe Wiesner; Kelly Chibale; Christo Muller
Journal:  Molecules       Date:  2017-03-30       Impact factor: 4.411

9.  Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.

Authors:  Victor Mangas-Sanjuan; Jorge Gutiérrez-Nieto; Magdalena Echezarreta-López; Isabel González-Álvarez; Marta González-Álvarez; Vicente-Germán Casabó; Marival Bermejo; Mariana Landin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.